Patents by Inventor Bertrand Perret

Bertrand Perret has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR THE CONTROL OF A POWER STEERING SYSTEM, COMPRISING A FIRST DRIVE AND A SECOND DRIVE AND IMPLEMENTING AN EVALUATION AND REGULATION STEP
    Publication number: 20220126911
    Abstract: A method for the control of a power steering system includes a first drive and a second drive which are arranged in parallel and implement an evaluation and regulation step calculating the first compensation request and the second compensation request as a function of the first deviation and of the second deviation.
    Type: Application
    Filed: January 29, 2020
    Publication date: April 28, 2022
    Applicant: JTEKT EUROPE
    Inventors: Guillaume CARPENTIER, Bertrand PERRET
  • Method for measuring the level of circulating inhibitory factor 1 protein in a subject measuring the level of circulating inhibitory factor 1 (IF1) protein in a subject
    Patent number: 9945871
    Abstract: The present invention relates to a method for assessing a subject's risk of having a cardiovascular disease comprising the step of measuring the level of IF1 in a body fluid sample obtained from said subject wherein the level of EF1 is negatively correlated with the risk of said subject of having cardiovascular disease.
    Type: Grant
    Filed: April 23, 2015
    Date of Patent: April 17, 2018
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE
    Inventors: Laurent Martinez, Bertrand Perret, Annelise Genoux
  • METHOD FOR ASSESSING A SUBJECT'S RISK OF HAVING A CARDIOVASCULAR DISEASE
    Publication number: 20150226749
    Abstract: The present invention relates to a method for assessing a subject's risk of having a cardiovascular disease comprising the step of measuring the level of IF1 in a body fluid sample obtained from said subject wherein the level of EF1 is negatively correlated with the risk of said subject of having cardiovascular disease.
    Type: Application
    Filed: April 23, 2015
    Publication date: August 13, 2015
    Applicants: Institut National de la Santé et de la Recherche Médicale (INSERM), CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE
    Inventors: Laurent MARTINEZ, Bertrand PERRET, Annelise GENOUX
  • Method for assessing a subject's risk of having a cardiovascular disease
    Patent number: 9052326
    Abstract: The present invention relates to a method for assessing a subject's risk of having a cardiovascular disease comprising the step of measuring the level of IF1 in a body fluid sample obtained from said subject wherein the level of EF1 is negatively correlated with the risk of said subject of having cardiovascular disease.
    Type: Grant
    Filed: January 25, 2012
    Date of Patent: June 9, 2015
    Assignees: Institut National de la Santé et de la Recherche Médicale (INSERM), CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE
    Inventors: Laurent Martinez, Bertrand Perret, Annelise Genoux
  • METHOD FOR ASSESSING A SUBJECT'S RISK OF HAVING A CARDIOVASCULAR DISEASE
    Publication number: 20130310315
    Abstract: The present invention relates to a method for assessing a subject's risk of having a cardiovascular disease comprising the step of measuring the level of IF1 in a body fluid sample obtained from said subject wherein the level of EF1 is negatively correlated with the risk of said subject of having cardiovascular disease.
    Type: Application
    Filed: January 25, 2012
    Publication date: November 21, 2013
    Applicants: Institut National de la Sante et de la Recherche Medicale(Inserm), CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE
    Inventors: Laurent Martinez, Bertrand Perret, Annelise Genoux
  • Use of Atp Analogues for Treatment of Cardiovascular Diseases
    Publication number: 20070249555
    Abstract: Use of N-alkyl-2-substituted ATP analogues, pharmaceutically acceptable salts, metabolites or prodrugs thereof, for the preparation of a medicament intended to be used in the prevention and/or the treatment of cardiovascular diseases, pharmaceutical compositions comprising such compounds and a method for screening such compounds.
    Type: Application
    Filed: June 7, 2005
    Publication date: October 25, 2007
    Applicant: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
    Inventors: Ronald Barbaras, Bertrand Perret, Corrine Rolland, Francois Terce, Jean-Marie Boeynaems, Xavier Collet, Sebastien Jacquet, Laurent Martinez
  • Lipoprotein receptor
    Publication number: 20040072368
    Abstract: This invention relates to the use of at least one domain of ATP synthase as a lipoprotein receptor.
    Type: Application
    Filed: September 12, 2002
    Publication date: April 15, 2004
    Inventors: Laurent Martinez, Sebastien Jacquet, Corinne Rolland, Francois Terce, Xavier Collet, Bertrand Perret, Ronald Barbaras, Eric Champagne, Jean-Pierre Esteve, John Walker, Michael Runswick